The Court of Justice of the European Union’s General Court has annulled a decision by the European Commission (EC) to withhold access to communications between its President and Pfizer, underscoring the importance of transparency within EU institutions. The court’s decision, as detailed in the ruling, indicates that the New York Times succeeded in challenging the EC’s stance that claiming non-existence or non-possession of documents is enough to deny access.
The case concerned an application made by a New York Times journalist under the Access to Documents Regulation, seeking text message exchanges between EC President Ursula von der Leyen and Pfizer CEO Albert Bourla during a critical period of vaccine negotiations amid the Covid-19 pandemic. The EC initially rejected this application, citing the non-availability of the requested documents. However, the court found that the newspaper presented consistent evidence to rebut this presumption.
In response to the court’s decision, the European Commission has committed to adopt a new decision that will provide a more detailed explanation as to why these documents were considered unavailable. This decision highlights the application of the Access to Documents Regulation, which underlines the EU’s commitment to transparency, as outlined in the fundamental principles of the European Union.
The principles of transparency and access to information are integral to the European legal framework, embodied in Articles 10 and 11 of the Treaty on European Union and Article 15 of the Treaty on the Functioning of the European Union. These provisions aim to ensure that citizens can scrutinize the activities of EU institutions, reinforcing public trust and accountability. The New York Times’ success in this legal challenge is a reminder of these critical freedoms and responsibilities.
For more details on the EU court’s ruling, you can view the original coverage by JURIST here.